Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

amyloid precursor protein

  • Research Article: New Research, Disorders of the Nervous System
    Phenotypic Differences between the Alzheimer’s Disease-Related hAPP-J20 Model and Heterozygous Zbtb20 Knock-Out Mice
    Daniel R. Gulbranson, Kaitlyn Ho, Gui-Qiu Yu, Xinxing Yu, Melanie Das, Eric Shao, Daniel Kim, Weiping J. Zhang, Krishna Choudhary, Reuben Thomas and Lennart Mucke
    eNeuro 8 April 2021, 8 (3) ENEURO.0089-21.2021; DOI: https://doi.org/10.1523/ENEURO.0089-21.2021
  • Research Article: New Research, Disorders of the Nervous System
    Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release
    Rémi Opsomer, Sabrina Contino, Florian Perrin, Roberta Gualdani, Bernadette Tasiaux, Pierre Doyen, Maxime Vergouts, Céline Vrancx, Anna Doshina, Nathalie Pierrot, Jean-Noël Octave, Philippe Gailly, Serena Stanga and Pascal Kienlen-Campard
    eNeuro 23 April 2020, 7 (3) ENEURO.0322-19.2020; DOI: https://doi.org/10.1523/ENEURO.0322-19.2020
  • New Research, Disorders of the Nervous System
    The Amyloid Precursor Protein Is a Conserved Receptor for Slit to Mediate Axon Guidance
    Baiping Wang, Hongmei Li, Sena A. Mutlu, Devon A. Bowser, Michael J. Moore, Meng C. Wang and Hui Zheng
    eNeuro 5 June 2017, 4 (3) ENEURO.0185-17.2017; DOI: https://doi.org/10.1523/ENEURO.0185-17.2017
  • New Research, Disorders of the Nervous System
    Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer’s Disease
    Lisa Kirouac, Alexander J. Rajic, David H. Cribbs and Jaya Padmanabhan
    eNeuro 17 March 2017, 4 (2) ENEURO.0149-16.2017; DOI: https://doi.org/10.1523/ENEURO.0149-16.2017
  • New Research, Disorders of the Nervous System
    APP Overexpression Causes Aβ-Independent Neuronal Death through Intrinsic Apoptosis Pathway
    Ning Cheng, Song Jiao, Ankita Gumaste, Li Bai and Leonardo Belluscio
    eNeuro 21 July 2016, 3 (4) ENEURO.0150-16.2016; DOI: https://doi.org/10.1523/ENEURO.0150-16.2016
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.